Healthy Life Agritec Limited has announced robust financial results for the first quarter, showcasing significant growth across key metrics on both standalone and consolidated bases.

Consolidated Performance Highlights

The company reported impressive consolidated revenue growth, with total income rising to Rs 4,276.33 crore, marking a substantial 23.38% increase from Rs 3,465.87 crore in the corresponding quarter of the previous year. This strong top-line performance was accompanied by a notable improvement in profitability.

Consolidated profit after tax (PAT) stood at Rs 82.98 crore, representing a 21.21% year-over-year growth compared to Rs 68.46 crore in the same quarter last year. This increase in profitability demonstrates the company's ability to effectively manage costs while driving revenue growth.

The earnings per share (EPS) on a consolidated basis improved to Rs 0.33, up from Rs 0.28 in the same quarter last year, reflecting the company's enhanced profitability on a per-share basis.

Standalone Performance

On a standalone basis, Healthy Life Agritec also delivered strong results:

Financial Position and Operational Efficiency

The company's balance sheet remains robust, with a paid-up equity share capital of Rs 2,481.20 crore. Healthy Life Agritec's ability to maintain strong growth while improving profitability indicates effective cost management and operational efficiency.

Management Commentary

Divya Mojjada, Managing Director of Healthy Life Agritec Limited, commented on the results, stating, "Our strong performance reflects the continued execution of our growth strategy and the resilience of our business model. The significant increase in both revenue and profitability across our standalone and consolidated operations underscores the strength of our core business and the value we deliver to our stakeholders."

Future Outlook

The company's board of directors approved these results on September 25. With its strong financial performance and growth trajectory, Healthy Life Agritec Limited appears well-positioned to capitalize on opportunities in the agritech sector.

Investors and stakeholders will be keenly watching the company's performance in the coming quarters, especially in light of the proposed Rights Issue scheduled to open on October 7, as mentioned in the company's regulatory filing.

Healthy Life Agritec's sustained growth and improved profitability in a competitive market environment signal positive momentum for the company as it moves forward in the fiscal year.

Healthy Life Agritec Limited , a company listed on the Bombay Stock Exchange (BSE: 543546), has announced a significant rights issue to raise up to ₹2,481.20 crore. The company's Board of Directors approved the issuance of up to 2,48,12,000 fully paid-up equity shares at ₹10 per share, maintaining a 1:1 ratio for existing shareholders.

Key Details of the Rights Issue

Important Dates

Impact on Share Capital

The rights issue, if fully subscribed, will double the company's outstanding equity shares from 2,48,12,000 to 4,96,24,000, each with a face value of ₹10.00.

Application Process

Shareholders will be required to pay the entire issue price of ₹10.00 per share at the time of application. The company has made arrangements with NSDL and CDSL for crediting the Rights Entitlements in dematerialized form to the demat accounts of eligible shareholders as of the record date.

Flexibility in Closing Date

The Board of Directors and/or the Rights Issue Committee retain the right to extend the closing date of the issue, subject to the total issue period not exceeding 30 days from the opening date.

Management Statement

Divya Mojjada, Managing Director of Healthy Life Agritec Limited, signed off on the rights issue announcement, which was made in compliance with SEBI Listing Regulations.

This rights issue represents a significant opportunity for existing shareholders to increase their stake in the company at the face value of the shares. Investors should carefully consider the terms and their financial position before participating in the rights issue.